1. Home
  2. PCRX vs CYH Comparison

PCRX vs CYH Comparison

Compare PCRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • CYH
  • Stock Information
  • Founded
  • PCRX 2006
  • CYH 1985
  • Country
  • PCRX United States
  • CYH United States
  • Employees
  • PCRX N/A
  • CYH N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • CYH Hospital/Nursing Management
  • Sector
  • PCRX Health Care
  • CYH Health Care
  • Exchange
  • PCRX Nasdaq
  • CYH Nasdaq
  • Market Cap
  • PCRX 1.2B
  • CYH 482.7M
  • IPO Year
  • PCRX 2011
  • CYH 1991
  • Fundamental
  • Price
  • PCRX $22.90
  • CYH $3.74
  • Analyst Decision
  • PCRX Buy
  • CYH Hold
  • Analyst Count
  • PCRX 8
  • CYH 8
  • Target Price
  • PCRX $28.38
  • CYH $4.27
  • AVG Volume (30 Days)
  • PCRX 525.8K
  • CYH 2.2M
  • Earning Date
  • PCRX 07-29-2025
  • CYH 07-23-2025
  • Dividend Yield
  • PCRX N/A
  • CYH N/A
  • EPS Growth
  • PCRX N/A
  • CYH N/A
  • EPS
  • PCRX N/A
  • CYH N/A
  • Revenue
  • PCRX $702,772,000.00
  • CYH $12,653,000,000.00
  • Revenue This Year
  • PCRX $7.92
  • CYH N/A
  • Revenue Next Year
  • PCRX $11.02
  • CYH $3.49
  • P/E Ratio
  • PCRX N/A
  • CYH N/A
  • Revenue Growth
  • PCRX 3.08
  • CYH 1.05
  • 52 Week Low
  • PCRX $11.16
  • CYH $2.24
  • 52 Week High
  • PCRX $27.64
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 35.82
  • CYH 56.80
  • Support Level
  • PCRX $22.82
  • CYH $3.44
  • Resistance Level
  • PCRX $23.83
  • CYH $3.64
  • Average True Range (ATR)
  • PCRX 0.74
  • CYH 0.17
  • MACD
  • PCRX -0.02
  • CYH 0.03
  • Stochastic Oscillator
  • PCRX 6.22
  • CYH 80.95

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: